Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.

Shahad W KattanYahya H HobaniSameerah ShaheenSara H MokhtarMohammad H HusseinEman A ToraihManal S FawzyHussein Abdelaziz Abdalla

Published in: Cellular & molecular biology letters (2021)

The findings support the putative role of CDKN2B-AS1 as an epigenetic marker in BC and open a new avenue for its potential use as a therapeutic molecular target in this type of cancer.

Keyphrases

gene expression
breast cancer risk
dna methylation
papillary thyroid
nucleic acid
squamous cell
minimally invasive
cell cycle
lymph node metastasis
free survival
squamous cell carcinoma
single molecule
cell cycle arrest
cell death